Skip to content

AHC International Media Library

Alternating Hemplegia of Childhood and ATP1A3 disorders

  • Interviews
  • Home Videos
  • News
  • Associations
  • Documentaries
  • Presentations
  • Contact
  • About AHCIM
  • Articles
  • Toggle search form

Dr Steven Gray talks about AAV gene therapy that can potentially help AHC patients.

Posted on November 4, 2018 By siggi


Dr. Steven Gray is one of the world leaders in developing gene therapies for rare and ultra-rare diseases. He works at the University of Texas Southwestern, where he is currently an Associate Professor in the Department of Pediatrics at the University of Texas Southwestern Medical Center.

Interviews Tags:aav, agusta fanney, AHC, ahcim, gene therapy, siggi johannesson, steven gray

Post navigation

Previous Post: Lynn Egan – Together we are strong
Next Post: Simon Frost at the ATP1A3 Symposium in Disease – Chicago 2018

Related Posts

Dr. Hendrik Rosewich -Optimistic about new discoveries Interviews
Simon Frost at the ATP1A3 Symposium in Disease – Chicago 2018 Interviews
Behind the Episode, an AHC advocacy podcast Associations
Helen Cross – ATP1A3 symposium London 2016 Interviews
Carmel in a Make-A-Wish Interview Interviews
Alfred George at the ATP1A3 symposium in disease, Chicago 2018 Interviews

Copyright © 2026 AHC International Media Library.

Powered by PressBook Masonry Dark